Is Circulation Research a Good Journal? An Honest Assessment
is circulation research a good journal: Circulation Research accepts ~10% of submissions and demands mechanistic depth. Here's who should submit to this to
Assistant Professor, Cardiovascular & Metabolic Disease
Author context
Works across cardiovascular biology and metabolic disease, with expertise in navigating high-impact journal submission requirements for Circulation, JACC, and European Heart Journal.
Journal fit
See whether this paper looks realistic for Circulation Research.
Run the Free Readiness Scan with Circulation Research as your target journal and see whether this paper looks like a realistic submission.
How to read Circulation Research as a target
This page should help you decide whether Circulation Research belongs on the shortlist, not just whether it sounds impressive.
Question | Quick read |
|---|---|
Best for | Circulation Research isn't looking for clinical trials or patient outcomes data - that's Circulation's. |
Editors prioritize | Mechanistic depth over phenomenology |
Think twice if | Submitting clinical or epidemiological studies |
Typical article types | Original Research Article, Brief Communication, Compendium Reviews |
Quick answer
Yes, Circulation Research is a good journal. Impact factor 16.2, ~10% acceptance rate, and it's the premier destination for basic cardiovascular science. If you're doing mechanistic cardiology research with multiple model systems, this is where your work belongs. Clinical researchers should look elsewhere.
Is Circulation Research a good journal? That question comes up constantly in cardiovascular labs, and the answer depends entirely on what kind of science you're doing.
Circulation Research sits at the top of basic cardiovascular science publishing. It's not trying to be everything to everyone. While its sister journal Circulation covers clinical trials and patient outcomes, Circulation Research focuses exclusively on mechanisms. If you're studying how hearts actually work at the molecular level, this is your target.
But here's what trips people up: the journal is brutally selective about what constitutes "basic" science. Submit a clinical study and you'll get desk rejected within days. Submit phenomenology without mechanistic depth and you'll face the same fate. The editors know exactly what they want, and they're not shy about rejecting everything else.
What Circulation Research Actually Publishes
Circulation Research publishes basic cardiovascular science. Period. That means molecular cardiology, vascular biology, cardiac electrophysiology, and heart failure mechanisms. Clinical trials, epidemiological studies, and patient outcome data get sent to Circulation instead.
The journal wants mechanistic depth. They're looking for papers that explain how cardiovascular processes work, not just that they happen. A study showing that protein X increases during heart failure won't cut it. But a study showing that protein X activates pathway Y, which then triggers cellular response Z, leading to specific functional changes? That's what gets accepted.
Molecular cardiology papers typically involve gene regulation, protein interactions, and cellular signaling in cardiomyocytes. Think studies on transcription factors controlling cardiac development, or how specific kinases regulate contractility. Recent accepted papers have covered topics like epigenetic regulation of cardiac hypertrophy and metabolic reprogramming in failing hearts.
Vascular biology covers endothelial function, smooth muscle cell behavior, and vessel wall mechanics. Papers might examine how shear stress regulates endothelial gene expression, or how inflammatory signals trigger atherosclerosis progression. The key is showing mechanism, not just association.
Cardiac electrophysiology means ion channels, action potential regulation, and arrhythmia mechanisms. Studies on how specific mutations alter channel function, or how metabolic stress affects electrical conduction, fit perfectly. Purely clinical EP studies don't.
Heart failure mechanisms focus on cellular and molecular changes during disease progression. That includes studies on calcium handling, mitochondrial dysfunction, or fibrosis signaling. But the work needs to reveal how these processes actually cause functional decline.
What gets rejected fast? Clinical observational studies. Device development papers. Health services research. Epidemiological analyses. Circulation Research editors know their scope and stick to it religiously.
Article types include Original Research Articles (the main category), Brief Communications for smaller but significant findings, and Compendium Reviews that synthesize current understanding. Research Commentaries provide perspective on particularly important papers.
The journal also publishes special issues focused on specific themes, like "Metabolism and the Heart" or "Vascular Inflammation." These issues maintain the same mechanistic standards but allow for more focused collections of related work.
The Numbers That Matter: 16.2 Impact Factor, 10% Acceptance Rate
Circulation Research has an impact factor of 16.2, putting it among the top cardiovascular journals worldwide. That's higher than most organ-specific journals manage, reflecting the quality and breadth of readership the journal commands.
The acceptance rate hovers around 10%. That makes it highly selective, but not impossibly so if your work fits the scope. Compare that to Nature or Science (acceptance rates around 7-8%), and Circulation Research becomes accessible for excellent basic cardiovascular research.
Initial editorial decisions typically come within 21-35 days. That's faster than many high-impact journals, where first decisions can take 6-8 weeks. The editors move quickly because they know their criteria well. Papers that don't fit get desk rejected immediately. Papers that do fit get sent out for peer review without delay.
The review process itself takes another 6-10 weeks typically, putting total time to first decision around 2-3 months for papers that go to review. That's reasonable for a journal of this caliber.
How does it compare to direct competitors? Cardiovascular Research has a somewhat lower citation profile but accepts slightly more submissions. Basic Research in Cardiology is more accessible for certain types of mechanistic work. Choosing between these options depends on your specific findings and approach.
The journal processes roughly 2,000 submissions annually and publishes around 200 papers. That math confirms the 10% acceptance rate and explains why getting in feels competitive but achievable for strong work.
What Editors Actually Want (And Common Rejection Reasons)
Circulation Research editors prioritize mechanistic depth over phenomenology. They want to know how things work, not just that they work differently in disease versus health. This isn't subtle preference - it's explicit editorial policy.
Novel findings that change understanding get priority. Incremental advances on well-studied pathways face an uphill battle unless they reveal truly unexpected mechanisms. The editors are looking for papers that will shift how the field thinks about cardiovascular biology.
Technical rigor means appropriate controls, sufficient sample sizes, and proper statistical analysis. The journal won't accept underpowered studies or experiments lacking key control groups. They expect authors to follow current guidelines for rigor and reproducibility.
Multiple model systems strengthen papers significantly. In vitro work alone rarely suffices. Combining cell culture, animal models, and when possible, human tissue samples creates compelling mechanistic stories. The more convergent evidence you provide, the stronger your case.
What triggers desk rejection? Clinical studies top the list. The editors reject these immediately because they belong in Circulation, not Circulation Research. Don't test this boundary - it's absolute.
Insufficient mechanistic explanation gets papers bounced quickly too. Describing what happens without explaining how it happens won't meet editorial standards. Your discussion needs to propose specific molecular mechanisms, preferably with supporting evidence.
Over-reliance on a single experimental approach creates problems. Papers based entirely on gene expression analysis, or solely on one animal model, struggle to get accepted. Editors want to see multiple lines of evidence pointing to the same mechanistic conclusion.
Inadequate statistical reporting includes missing power calculations, inappropriate statistical tests, or failure to account for multiple comparisons. The journal has strict standards here, reflecting broader scientific community expectations.
Phenomenological studies get rejected even when technically sound. Showing that biomarker levels differ between groups isn't enough. You need to demonstrate what causes those differences and what functional consequences result.
The editors also reject studies that duplicate recent publications without substantial advancement. They track the literature carefully and won't publish variations on recently published themes unless the new work genuinely extends understanding.
Common revision requests include adding mechanistic experiments, strengthening statistical analyses, and clarifying the significance of findings for cardiovascular biology broadly. Papers that can address these concerns usually get accepted after revision.
Circulation Research vs The Competition
Circulation Research competes directly with several other cardiovascular journals, each with distinct positioning. Understanding these differences helps you pick the right target.
Cardiovascular Research covers similar basic science territory but accepts more translational work. If your mechanistic findings have clear clinical implications, Cardiovascular Research might be more receptive. They're also more accepting of single-model studies that tell complete stories.
Basic Research in Cardiology focuses heavily on cardiac-specific mechanisms rather than broader cardiovascular biology. If your work centers on heart function specifically, rather than vascular biology or systemic cardiovascular regulation, this journal might fit better. The acceptance rate is higher, making it a reasonable backup option.
Journal of Molecular and Cellular Cardiology accepts mechanistic work but with less stringent impact requirements. Papers that reveal important mechanisms but don't necessarily change field-wide thinking can find homes here. The technical standards remain high, but the novelty bar is lower.
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) covers the vascular side of cardiovascular research specifically. If your work focuses on blood vessels, atherosclerosis, or thrombosis mechanisms, ATVB might be more targeted than Circulation Research's broader scope.
The choice often comes down to scope and ambition. Circulation Research demands broad significance for cardiovascular biology. The competitor journals allow for more specialized or incremental advances. If your mechanistic findings will interest cardiologists, vascular biologists, and cardiovascular physiologists equally, aim for Circulation Research. If your audience is more specialized, consider the focused alternatives.
The Verdict: Who Should Submit
Submit if you're doing mechanistic cardiovascular research with multiple model systems. Your work should reveal how cardiovascular processes function at the molecular or cellular level. Strong candidates include studies that identify new signaling pathways, characterize novel regulatory mechanisms, or explain disease pathogenesis through basic science approaches.
Think twice if you're doing clinical research, epidemiological studies, or device development work. Circulation Research won't consider these paper types regardless of quality. Also reconsider if your work is purely phenomenological or relies on a single experimental approach.
Perfect fits include molecular cardiologists with convergent evidence from cell culture, animal models, and human samples. Vascular biologists who can explain endothelial or smooth muscle function mechanistically. Cardiac electrophysiologists with ion channel or conduction mechanism data.
Poor fits include clinical trialists, epidemiologists studying cardiovascular risk factors, bioengineers developing devices, and health services researchers. These fields produce valuable work, but not for this journal.
Bottom Line
Circulation Research is an excellent journal if you're doing basic cardiovascular science. The 16.2 impact factor reflects genuine quality and influence in the field. The 10% acceptance rate means selectivity without impossibility for appropriate work.
Submit if your research reveals cardiovascular mechanisms through rigorous basic science approaches. You have multiple lines of evidence pointing to specific molecular or cellular processes. Your findings will interest the broad cardiovascular research community.
Think twice if your work is clinical, epidemiological, or device-focused. You're relying on single experimental approaches. Your findings are incremental advances on well-studied pathways.
The journal knows what it wants and rejects everything else quickly. That clarity actually helps authors - you won't waste months in review if your work doesn't fit. But if it does fit and meets their technical standards, Circulation Research provides the best platform for basic cardiovascular science publishing.
For mechanistic cardiovascular researchers, this journal represents the gold standard. The editorial standards are high but fair. The review process is efficient. And publication here genuinely advances careers in cardiovascular research. Avoiding common preparation mistakes will maximize your chances of getting through the initial editorial screen.
- Circulation Research submission statistics and acceptance rates from editorial board reports 2023-2024
- Comparative analysis of cardiovascular journal metrics and positioning from Web of Science database
Need help preparing your cardiovascular research for submission? ManuSights provides pre-submission manuscript review specifically designed to catch the kinds of issues that lead to desk rejection at selective journals like Circulation Research.
Jump to key sections
Sources
- 1. Journal Citation Reports 2024 - Circulation Research impact factor and ranking data
- 2. American Heart Association editorial policies for Circulation Research journal scope and article types
Final step
See whether this paper fits Circulation Research.
Run the Free Readiness Scan with Circulation Research as your target journal and get a manuscript-specific fit signal before you commit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Need deeper scientific feedback? See Expert Review Options
Where to go next
Start here
Same journal, next question
Supporting reads
Conversion step
See whether this paper fits Circulation Research.
Anthropic Privacy Partner. Zero-retention manuscript processing.